Correlation Between HCW Biologics and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on HCW Biologics and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Pasithea Therapeutics.
Diversification Opportunities for HCW Biologics and Pasithea Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Pasithea is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and Pasithea Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to generate 14.77 times more return on investment than Pasithea Therapeutics. However, HCW Biologics is 14.77 times more volatile than Pasithea Therapeutics Corp. It trades about 0.13 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.05 per unit of risk. If you would invest 44.00 in HCW Biologics on August 30, 2024 and sell it today you would earn a total of 6.21 from holding HCW Biologics or generate 14.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 54.55% |
| Values | Daily Returns |
HCW Biologics vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| HCW Biologics |
| Pasithea Therapeutics |
HCW Biologics and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Pasithea Therapeutics
The main advantage of trading using opposite HCW Biologics and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Pasithea Therapeutics vs. Pasithea Therapeutics Corp | Pasithea Therapeutics vs. Biofrontera Warrants | Pasithea Therapeutics vs. Lixte Biotechnology Holdings | Pasithea Therapeutics vs. Jasper Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |